Microglial Phenotypes and Functions in Multiple Sclerosis
Open accessThe DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Abstract
Microglia are the resident immune cells that constantly survey the central nervous system. They can adapt to their environment and respond to injury or insult by altering their morphology, phenotype, and functions. It has long been debated whether microglial activation is detrimental or beneficial in multiple sclerosis (MS). Recently, the two opposing yet connected roles of microglial activation have been described with the aid of novel microglial markers, RNA profiling, and in vivo models. In this review, microglial phenotypes and functions in the context of MS will be discussed with evidence from both human pathological studies, in vitro and in vivo models. Microglial functional diversity-phagocytosis, antigen presentation, immunomodulation, support, and repair-will also be examined in detail. In addition, this review discusses the emerging evidence for microglia-related targets as biomarkers and therapeutic targets for MS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neurotoxic reactive astrocytes are induced by activated microglia
Liddelow, S. A., Guttenplan, K. A., Clarke, L. E., Bennett, F. C., Bohlen, C. J., Schirmer, L., Bennett, M. L., Münch, A. E., Chung, W.-S., Peterson, T. C., et al. (2017) · Nature · doi:10.1038/nature21029 · Cited by 7,971
The M1 and M2 paradigm of macrophage activation: Time for reassessment
Martinez, F. O., & Gordon, S. (2014) · F1000Prime Reports · doi:10.12703/p6-13 · Cited by 4,689 · cited 1×
“Indeed, microglia and macrophages have been wrongly classified as pro- versus anti-inflammatory cells (Martinez and Gordon 2014; Ransohoff 2016).”
BackgroundAxonal transection in the lesions of multiple sclerosis
Trapp, B. D., Peterson, J., Ransohoff, R. M., Rudick, R., Mörk, S., & Bö, L. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801293380502 · Cited by 4,029
Kettenmann, H., Hanisch, U.-K., Noda, M., & Verkhratsky, A. (2011) · Physiological Reviews · doi:10.1152/physrev.00011.2010 · Cited by 3,547 · cited 2×
“However, microglia can transform into a macrophage phenotype (Kettenmann et al. 2011).”
BackgroundKrasemann, S., Madore, C., Cialic, R., Baufeld, C., Calcagno, N., El Fatimy, R., Beckers, L., O’Loughlin, E., Xu, Y., Fanek, Z., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.08.008 · Cited by 2,979 · cited 1×
“TREM2 expression by microglia is known to modulate the inflammatory response by suppression of microglia-mediated cytokine production and secretion, and by regulation of phagocytic pathways that clear neuronal debris (Hsieh et al. 2009; Krasemann et al. 2017).”
BackgroundSelf-citationIdentification of a unique TGF-β–dependent molecular and functional signature in microglia
Butovsky, O., Jedrychowski, M. P., Moore, C. S., Cialic, R., Lanser, A. J., Gabriely, G., Koeglsperger, T., Dake, B., Wu, P. M., Doykan, C. E., et al. (2014) · Nature Neuroscience · doi:10.1038/nn.3599 · Cited by 2,543 · cited 3×
“However, with the advancement of specific markers and identification of molecular signatures of these cells, significant advancements are being made in this field (Butovsky et al. 2014; Rinchai et al. 2016).”
BackgroundSelf-citationNew tools for studying microglia in the mouse and human CNS
Bennett, M. L., Bennett, F. C., Liddelow, S. A., Ajami, B., Zamanian, J. L., Fernhoff, N. B., Mulinyawe, S. B., Bohlen, C. J., Adil, A., Tucker, A., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1525528113 · Cited by 1,804
Compston, A., & Coles, A. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08220-x · Cited by 1,743
A polarizing question: do M1 and M2 microglia exist?
Ransohoff, R. M. (2016) · Nature Neuroscience · doi:10.1038/nn.4338 · Cited by 1,573
Control of microglial neurotoxicity by the fractalkine receptor
Cardona, A. E., Pioro, E. P., Sasse, M. E., Kostenko, V., Cardona, S. M., Dijkstra, I. M., Huang, D., Kidd, G., Dombrowski, S., Dutta, R., et al. (2006) · Nature Neuroscience · doi:10.1038/nn1715 · Cited by 1,531 · cited 2×
“Moreover, in models for Parkinson’s and amyotrophic lateral sclerosis (ALS), mice lacking the fractalkine receptor showed significant neuronal loss, showing the potential for microglial neuroprotection via the CX3CR1 receptor (Cardona et al. 2006).”
BackgroundPerivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo
Hickey, W. F., & Kimura, H. (1988) · Science · doi:10.1126/science.3276004 · Cited by 1,466 · cited 1×
“…chimeric animals, no differences in EAE incidence and severity was seen after passive transfer of encephalitogenic T cells irrespective of whether antigen recognition tookplace onlyon recruitedmyeloid cells or on these cells together with microglia (Hickey and Kimura 1988; Lassmann et al. 1993).”
BackgroundThe relation between inflammation and neurodegeneration in multiple sclerosis brains
Frischer, J. M., Bramow, S., Dal-Bianco, A., Lucchinetti, C. F., Rauschka, H., Schmidbauer, M., Laursen, H., Sorensen, P. S., & Lassmann, H. (2009) · Brain · doi:10.1093/brain/awp070 · Cited by 1,450
Self-citationInnate immune activation in neurodegenerative disease
Heneka, M. T., Kummer, M. P., & Latz, E. (2014) · Nature Reviews Immunology · doi:10.1038/nri3705 · Cited by 1,437 · cited 2×
“Activated amoeboid microglia can induce detrimental cellular damage to the host by releasing anumberof inflammatory mediators, including proinflammatory cytokines, ROS, RNI, and various complement proteins (Mayo et al. 2012; Gonzalez et al. 2014; Heneka et al. 2014).”
BackgroundThe Immunopathology of Multiple Sclerosis: An Overview
Lassmann, H., Brück, W., & Lucchinetti, C. F. (2007) · Brain Pathology · doi:10.1111/j.1750-3639.2007.00064.x · Cited by 1,182
Self-citationMicroglial priming in neurodegenerative disease
Perry, V. H., & Holmes, C. (2014) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.38 · Cited by 1,127
Mitochondrial DNA in innate immune responses and inflammatory pathology
West, A. P., & Shadel, G. S. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2017.21 · Cited by 1,115
El-Behi, M., Ciric, B., Dai, H., Yan, Y., Cullimore, M., Safavi, F., Zhang, G.-X., Dittel, B. N., & Rostami, A. (2011) · Nature Immunology · doi:10.1038/ni.2031 · Cited by 1,071 · cited 1×
“In vivo, GM-CSF was shown to be essential in the induction of encephalitogenic CD4+ T cells in EAE (El-Behi et al. 2011).”
BackgroundInfiltrating monocytes trigger EAE progression, but do not contribute to the resident microglia pool
Ajami, B., Bennett, J. L., Krieger, C., McNagny, K. M., & Rossi, F. M. V. (2011) · Nature Neuroscience · doi:10.1038/nn.2887 · Cited by 1,061 · cited 2×
“Recruited immune cells infiltrate the lesions, and monocyte infiltrates have been shown to play a critical role in the establishment of EAE that is distinct from microglia (Mildner et al. 2009; Ajami et al. 2011).”
BackgroundA microRNA array reveals extensive regulation of microRNAs during brain development
KRICHEVSKY, A. M., KING, K. S., DONAHUE, C. P., KHRAPKO, K., & KOSIK, K. S. (2003) · RNA · doi:10.1261/rna.5980303 · Cited by 1,040 · cited 1×
“MiR-124 is one of the most abundant miRNAs in the brain, accounting for more than a quarter of all miRNAs (Krichevsky et al. 2003).”
BackgroundMutations in ADAR1 cause Aicardi-Goutières syndrome associated with a type I interferon signature
Rice, G. I., Kasher, P. R., Forte, G. M. A., Mannion, N. M., Greenwood, S. M., Szynkiewicz, M., Dickerson, J. E., Bhaskar, S. S., Zampini, M., Briggs, T. A., et al. (2012) · Nature Genetics · doi:10.1038/ng.2414 · Cited by 923
Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis
Greter, M., Heppner, F. L., Lemos, M. P., Odermatt, B. M., Goebels, N., Laufer, T., Noelle, R. J., & Becher, B. (2005) · Nature Medicine · doi:10.1038/nm1197 · Cited by 862 · cited 1×
“…necrosis factor α [TNF-α] and interferon γ [IFN-γ]) and toxicmolecules, which further amplify the initial activation, proliferation, and differentiation of T cells (Greter et al. 2005; Heppner et al. 2005; McMahon et al. 2005), and they lead to neuronal dysfunction and chronic brain inflammation.”
BackgroundDifferential roles of microglia and monocytes in the inflamed central nervous system
Yamasaki, R., Lu, H., Butovsky, O., Ohno, N., Rietsch, A. M., Cialic, R., Wu, P. M., Doykan, C. E., Lin, J., Cotleur, A. C., et al. (2014) · Journal of Experimental Medicine · doi:10.1084/jem.20132477 · Cited by 856
Self-citationPonomarev, E. D., Veremeyko, T., Barteneva, N., Krichevsky, A. M., & Weiner, H. L. (2011) · Nature Medicine · doi:10.1038/nm.2266 · Cited by 787 · cited 2×
“An interesting study by Ponomarev et al. (2011) showed that miR-124 was affected in EAE disease progression.”
BackgroundExperimental autoimmune encephalomyelitis repressed by microglial paralysis
Heppner, F. L., Greter, M., Marino, D., Falsig, J., Raivich, G., Hövelmeyer, N., Waisman, A., Rülicke, T., Prinz, M., Priller, J., et al. (2005) · Nature Medicine · doi:10.1038/nm1177 · Cited by 732 · cited 5×
“…using bone marrow chimeric mice showed that microglia activation precedes the onset of EAE and thatmicroglia depletion or down-regulation of microglial genes results in attenuation of disease severity and demyelination in EAE (Heppner et al. 2005; Ponomarev et al. 2005; Goldmann et al. 2013).”
BackgroundInfluentialA reversible form of axon damage in experimental autoimmune encephalomyelitis and multiple sclerosis
Nikić, I., Merkler, D., Sorbara, C., Brinkoetter, M., Kreutzfeldt, M., Bareyre, F. M., Brück, W., Bishop, D., Misgeld, T., & Kerschensteiner, M. (2011) · Nature Medicine · doi:10.1038/nm.2324 · Cited by 713 · cited 2×
“Microglia activation with subsequent oxidative damage is also seen in experimental rodent models (Nikic et al. 2011), but extensive chronic oxidative damage with massive mitochondrial injury and gene deletion, as seen typically in MS lesions, is lacking in rodent models of inflammation and/or demyelination so far (Sch…”
BackgroundEpitope spreading initiates in the CNS in two mouse models of multiple sclerosis
McMahon, E. J., Bailey, S. L., Castenada, C. V., Waldner, H., & Miller, S. D. (2005) · Nature Medicine · doi:10.1038/nm1202 · Cited by 694 · cited 6×
“APCs are essential for the pathogenesis of EAE (McMahon et al. 2005).”
BackgroundInfluentialLoss of ‘homeostatic’ microglia and patterns of their activation in active multiple sclerosis
Zrzavy, T., Hametner, S., Wimmer, I., Butovsky, O., Weiner, H. L., & Lassmann, H. (2017) · Brain · doi:10.1093/brain/awx113 · Cited by 684 · cited 11×
“Microglia senescence is particularly prominent in the brain of aging patients with progressive MS and is associated with a prominent loss of microglia and macrophages in inactive lesions in comparison to the normal-appearing white matter (Hametner et al. 2013; Zrzavy et al. 2017).”
BackgroundInfluentialSelf-citationAging-induced type I interferon response at the choroid plexus negatively affects brain function
Baruch, K., Deczkowska, A., David, E., Castellano, J. M., Miller, O., Kertser, A., Berkutzki, T., Barnett-Itzhaki, Z., Bezalel, D., Wyss-Coray, T., et al. (2014) · Science · doi:10.1126/science.1252945 · Cited by 615 · cited 1×
“Although they signal through different pathways, they both induce a pronounced type 1 IFN response, which primarily functions to suppress virus infection, but when overexaggerated may by itself induce cell damage in the brain (Rice et al. 2012; Baruch et al. 2014).”
BackgroundTREM2 sustains microglial expansion during aging and response to demyelination
Poliani, P. L., Wang, Y., Fontana, E., Robinette, M. L., Yamanishi, Y., Gilfillan, S., & Colonna, M. (2015) · Journal of Clinical Investigation · doi:10.1172/jci77983 · Cited by 525 · cited 2×
“Microglia density in the CNS tissue increases with age (Poliani et al. 2015), but a subset of these cells inhumans, highlyexpressing ferritin, shows signs of dystrophy or senescence, characterized by a reduction and beading of cell processes (Lopes et al.”
BackgroundMultiple sclerosis: experimental models and reality
Lassmann, H., & Bradl, M. (2017) · Acta Neuropathologica · doi:10.1007/s00401-016-1631-4 · Cited by 525
Self-citationIron and neurodegeneration in the multiple sclerosis brain
Hametner, S., Wimmer, I., Haider, L., Pfeifenbring, S., Brück, W., & Lassmann, H. (2013) · Annals of Neurology · doi:10.1002/ana.23974 · Cited by 519
Self-citationHuitinga, I., van Rooijen, N., de Groot, C. J., Uitdehaag, B. M., & Dijkstra, C. D. (1990) · The Journal of experimental medicine · doi:10.1084/jem.172.4.1025 · Cited by 506 · cited 1×
“It has been observed in MS and in EAE mouse models (Williams et al. 1994; Ransohoff 2012) that macrophages predominate in demyelinated areas and their numbers correlate to EAE severity and disease progression (Huitinga et al. 1990, 1993; Ferguson et al. 1997; Trapp et al. 1998; Ajami et al. 2011).”
BackgroundThe Cytokine GM-CSF Drives the Inflammatory Signature of CCR2+ Monocytes and Licenses Autoimmunity
Croxford, A. L., Lanzinger, M., Hartmann, F. J., Schreiner, B., Mair, F., Pelczar, P., Clausen, B. E., Jung, S., Greter, M., & Becher, B. (2015) · Immunity · doi:10.1016/j.immuni.2015.08.010 · Cited by 484
Macrophages in inflammatory multiple sclerosis lesions have an intermediate activation status
Vogel, D. Y., Vereyken, E. J., Glim, J. E., Heijnen, P. D., Moeton, M., van der Valk, P., Amor, S., Teunissen, C. E., van Horssen, J., & Dijkstra, C. D. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-35 · Cited by 479 · cited 3×
“with higher expression ofMHCclass I and II and costimulatory molecules, and secrete different inflammatory and neurotoxic mediators in lesions (Boven et al. 2006; Butovsky et al. 2006; Huizinga et al. 2012; Vogel et al. 2013).”
BackgroundA role for TREM2 ligands in the phagocytosis of apoptotic neuronal cells by microglia
Hsieh, C. L., Koike, M., Spusta, S. C., Niemi, E. C., Yenari, M., Nakamura, M. C., & Seaman, W. E. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06042.x · Cited by 475 · cited 1×
“TREM2 expression by microglia is known to modulate the inflammatory response by suppression of microglia-mediated cytokine production and secretion, and by regulation of phagocytic pathways that clear neuronal debris (Hsieh et al. 2009; Krasemann et al. 2017).”
BackgroundSlow expansion of multiple sclerosis iron rim lesions: pathology and 7 T magnetic resonance imaging
Dal-Bianco, A., Grabner, G., Kronnerwetter, C., Weber, M., Höftberger, R., Berger, T., Auff, E., Leutmezer, F., Trattnig, S., Lassmann, H., et al. (2017) · Acta Neuropathologica · doi:10.1007/s00401-016-1636-z · Cited by 463 · cited 4×
“Such iron ring lesions label a subset of slowly expanding lesions in the brain of patients with progressive MS (Pitt et al. 2010) and may turn out in the future to be a paraclinical marker for low-grade lesion activity in patients (Pitt et al. 2010; Dal-Bianco et al. 2017).”
BackgroundInfluentialSelf-citationMildner, A., Mack, M., Schmidt, H., Brück, W., Djukic, M., Zabel, M. D., Hille, A., Priller, J., & Prinz, M. (2009) · Brain · doi:10.1093/brain/awp144 · Cited by 445 · cited 1×
“Recruited immune cells infiltrate the lesions, and monocyte infiltrates have been shown to play a critical role in the establishment of EAE that is distinct from microglia (Mildner et al. 2009; Ajami et al. 2011).”
BackgroundOligodendrocyte‐microglia cross‐talk in the central nervous system
Peferoen, L., Kipp, M., van der Valk, P., van Noort, J. M., & Amor, S. (2014) · Immunology · doi:10.1111/imm.12163 · Cited by 438 · cited 2×
“Studies have revealed that stressed oligodendrocytes activate microglia (Peferoen et al. 2014).”
BackgroundPraet, J., Guglielmetti, C., Berneman, Z., Van der Linden, A., & Ponsaerts, P. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.10.004 · Cited by 435
TMEM119 marks a subset of microglia in the human brain
Satoh, J., Kino, Y., Asahina, N., Takitani, M., Miyoshi, J., Ishida, T., & Saito, Y. (2016) · Neuropathology · doi:10.1111/neup.12235 · Cited by 434
Mitochondrial defects in acute multiple sclerosis lesions
Mahad, D., Ziabreva, I., Lassmann, H., & Turnbull, D. (2008) · Brain · doi:10.1093/brain/awn105 · Cited by 406
Self-citationThe topograpy of demyelination and neurodegeneration in the multiple sclerosis brain
Haider, L., Zrzavy, T., Hametner, S., Höftberger, R., Bagnato, F., Grabner, G., Trattnig, S., Pfeifenbring, S., Brück, W., & Lassmann, H. (2016) · Brain · doi:10.1093/brain/awv398 · Cited by 400
Self-citationMyelin-laden macrophages are anti-inflammatory, consistent with foam cells in multiple sclerosis
Boven, L. A., Van Meurs, M., Van Zwam, M., Wierenga-Wolf, A., Hintzen, R. Q., Boot, R. G., Aerts, J. M., Amor, S., Nieuwenhuis, E. E., & Laman, J. D. (2006) · Brain · doi:10.1093/brain/awh707 · Cited by 353 · cited 1×
“…Med 2018;8:a028993 11 w w w .p er sp ec ti ve si n m ed ic in e. o rg with higher expression ofMHCclass I and II and costimulatory molecules, and secrete different inflammatory and neurotoxic mediators in lesions (Boven et al. 2006; Butovsky et al. 2006; Huizinga et al. 2012; Vogel et al. 2013).”
BackgroundGonzález, H., Elgueta, D., Montoya, A., & Pacheco, R. (2014) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2014.07.012 · Cited by 352 · cited 3×
“Activated amoeboid microglia can induce detrimental cellular damage to the host by releasing anumberof inflammatory mediators, including proinflammatory cytokines, ROS, RNI, and various complement proteins (Mayo et al. 2012; Gonzalez et al. 2014; Heneka et al. 2014).”
BackgroundMildner, A., Huang, H., Radke, J., Stenzel, W., & Priller, J. (2017) · Glia · doi:10.1002/glia.23097 · Cited by 301 · cited 2×
“Similar results have been reported previously, although they were only based on a single MS lesion (Mildner et al. 2017).”
BackgroundResultCortical lesions in multiple sclerosis
Calabrese, M., Filippi, M., & Gallo, P. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.93 · Cited by 269
Lopes, K. O., Sparks, D. L., & Streit, W. J. (2008) · Glia · doi:10.1002/glia.20678 · Cited by 262 · cited 2×
“Microglia density in the CNS tissue increases with age (Poliani et al. 2015), but a subset of these cells inhumans, highlyexpressing ferritin, shows signs of dystrophy or senescence, characterized by a reduction and beading of cell processes (Lopes et al. 2008).”
BackgroundButovsky, O. (2006) · Journal of Clinical Investigation · doi:10.1172/jci26836 · Cited by 261 · cited 3×
“with higher expression ofMHCclass I and II and costimulatory molecules, and secrete different inflammatory and neurotoxic mediators in lesions (Boven et al. 2006; Butovsky et al. 2006; Huizinga et al. 2012; Vogel et al. 2013).”
BackgroundSelf-citationPositron emission tomography and functional characterization of a complete PBR/TSPO knockout
Banati, R. B., Middleton, R. J., Chan, R., Hatty, C. R., Wai-Ying Kam, W., Quin, C., Graeber, M. B., Parmar, A., Zahra, D., Callaghan, P., et al. (2014) · Nature Communications · doi:10.1038/ncomms6452 · Cited by 241
USP18 lack in microglia causes destructive interferonopathy of the mouse brain
Goldmann, T., Zeller, N., Raasch, J., Kierdorf, K., Frenzel, K., Ketscher, L., Basters, A., Staszewski, O., Brendecke, S. M., Spiess, A., et al. (2015) · The EMBO Journal · doi:10.15252/embj.201490791 · Cited by 223 · cited 1×
“…macrophage and possibly microglia activation, either through vesicular TLRs (TLR7 and 9) or intracellular pathways of RNA recognition involving mitochon- 12 Cite this article as Cold Spring Harb Perspect Med 2018;8:a028993 w w w .p er sp ec ti ve si n m ed ic in e. o rg dria (Goldmann et al. 2015).”
BackgroundMechanisms of white matter damage in multiple sclerosis
Lassmann, H. (2014) · Glia · doi:10.1002/glia.22597 · Cited by 191 · cited 1×
“Active demyelination is associated with inflammation and reactive microgliosis (Lassmann 2014).”
BackgroundSelf-citationPeferoen, L. A. N., Vogel, D. Y. S., Ummenthum, K., Breur, M., Heijnen, P. D. A. M., Gerritsen, W. H., Peferoen-Baert, R. M. B., van der Valk, P., Dijkstra, C. D., & Amor, S. (2015) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0000000000000149 · Cited by 178 · cited 1×
“Macrophages and microglia were considered to present an intermediate phenotype in human MS lesions (Vogel et al. 2013; Peferoen et al. 2015) with a predominance of proinflammatory phenotypes during the acute or early phase of disease (Gao and Tsirka 2011).”
BackgroundRissanen, E., Tuisku, J., Rokka, J., Paavilainen, T., Parkkola, R., Rinne, J. O., & Airas, L. (2014) · Journal of Nuclear Medicine · doi:10.2967/jnumed.113.131698 · Cited by 171 · cited 1×
“[11C]PK11195 binding was increased in areas of acute and relapse-associated inflammation (Rissanen et al. 2014).”
BackgroundPreactive lesions in multiple sclerosis
van der Valk, P., & Amor, S. (2009) · Current Opinion in Neurology · doi:10.1097/wco.0b013e32832b4c76 · Cited by 156 · cited 1×
“Activated microglia are present during early and late MS stages (van der Valk and Amor 2009; Singh et al. 2013).”
BackgroundWlodarczyk, A., Løbner, M., Cédile, O., & Owens, T. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-57 · Cited by 149 · cited 1×
“Once activated, T cells traffic/move into the CNS and become restimulated by APCs (microg- lia) thus leading to further inflammatory cascade and disease progression (Wlodarczyk et al. 2014).”
Background
Cited by
van der Poel, M., Ulas, T., Mizee, M. R., Hsiao, C.-C., Miedema, S. S. M., Adelia, Schuurman, K. G., Helder, B., Tas, S. W., Schultze, J. L., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-08976-7 · Cited by 306
Tmem119-EGFP and Tmem119-CreERT2 Transgenic Mice for Labeling and Manipulating Microglia
Kaiser, T., & Feng, G. (2019) · eneuro · doi:10.1523/eneuro.0448-18.2019 · Cited by 259
Tmem119-EGFP and Tmem119-CreERT2 transgenic mice for labeling and manipulating microglia
Kaiser, T., & Feng, G. (2019) · doi:10.1101/624825 · Cited by 258
CNS remyelination and inflammation: From basic mechanisms to therapeutic opportunities
Franklin, R. J. M., & Simons, M. (2022) · Neuron · doi:10.1016/j.neuron.2022.09.023 · Cited by 184
Csf1R inhibition attenuates experimental autoimmune encephalomyelitis and promotes recovery
Nissen, J. C., Thompson, K. K., West, B. L., & Tsirka, S. E. (2018) · Experimental Neurology · doi:10.1016/j.expneurol.2018.05.021 · Cited by 168
Metadata
- Authors
- O’Loughlin, E., Madore, C., Lassmann, H., & Butovsky, O.
- Venue
- Cold Spring Harbor Perspectives in Medicine
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2018-02
- Volume
- 8
- Issue
- 2
- Pages
- a028993
- ISSN
- 2157-1422 (ISSN-L)
- OpenAlex
- W2786979675
- Cited by
- 124
- References
- 55
- Type
- posted content
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.